Results 221 to 230 of about 43,226 (268)
Some of the next articles are maybe not open access.

Weakness after Gastric Bypass

Obesity Surgery, 2002
Two patients underwent gastric bypasses and had uneventful hospital courses. In the early postoperative periods, both developed severe, protracted vomiting, weakness, and hyporeflexia. After thorough laboratory and clinical evaluations by neurologists, the patients were diagnosed with Guillain-Barré syndrome, although there were many atypical features.
Craig G, Chang   +3 more
openaire   +2 more sources

Gastric bypass in morbid obesity

The American Journal of Clinical Nutrition, 1980
Gastric operations for the treatment of morbid obesity have been standardized. They require close adherence to specifications for success. The upper stomach volume should be measured intraoperatively and fashioned to a capacity of 50 ml at a pressure of 25 to 30 cm of saline. The outlet should be no larger than 12 mm in diameter.
E E, Mason   +4 more
openaire   +2 more sources

Evolution of the Laparoscopic Gastric Bypass

Journal of Laparoendoscopic & Advanced Surgical Techniques, 2003
Obesity is recognized as a health problem of epidemic proportions. Surgical intervention for the treatment of obesity is a well-studied and effective method. Various procedures have been utilized over the past decades. Roux-en-Y gastric bypass has emerged over the last 20 years and is currently the most commonly offered surgical treatment.
Virginia, McGrath   +2 more
openaire   +2 more sources

Treatment of NASH with Gastric Bypass

Current Gastroenterology Reports, 2018
Nonalcoholic steatohepatitis (NASH) is a spectrum of nonalcoholic fatty liver disease (NAFLD). It is defined as the presence of fatty liver along with inflammation and hepatocyte injury. To date, weight loss achieved via lifestyle intervention remains the mainstay of NASH treatment.
Pichamol, Jirapinyo   +1 more
openaire   +2 more sources

Gastric-bypass-induced pneumothorax

Gastrointestinal Radiology, 1985
Substernal gastric bypass has been recently revived to palliate unresectable esophageal carcinoma. We report an unusual postoperative complication of gastric bypass: recurrent pneumothorax responding to nasogastric tube decompression of a distended thoracic stomach.
S J, Pomeranz, J F, Wiot
openaire   +2 more sources

Outcome of Gastric Bypass Patients

Obesity Surgery, 2002
The authors analyzed previously studied outcomes of Roux-en-Y gastric bypass (RYGBP), examined pre-surgical factors of post-surgical outcomes, and examined some of the psychosocial benefits.A retrospective chart review was conducted of 138 patients who underwent RYGBP between 1997 and 2000.
Ryan, Holzwarth   +3 more
openaire   +2 more sources

Gastric Bypass with Biliopancreatic Diversion

Gastroenterology Clinics of North America, 1987
Gastric bypass with biliopancreatic diversion (GBBPD) is a combined restrictive and malabsorptive procedure for the treatment of morbid obesity.
L M, DeLucia   +3 more
openaire   +2 more sources

Gastric bypass and glucose metabolism

Internal Medicine Journal, 2009
AbstractRoux‐en‐Y gastric bypass leads to a marked improvement of glucose control. The mechanisms are only partly known. Gastrointestinal hormones may play a role. Of these, glucagon‐like peptide 1 and peptide YY have been most consistently associated with the beneficial effects of gastric bypass on glucose metabolism and weight. In this paper, a short
openaire   +2 more sources

Gastric Bypass Operation for Obesity

World Journal of Surgery, 1998
AbstractGastric bypass is considered by many to be the gold standard for surgical treatment of obesity. Gastric bypass was a natural evolution from gastric operations that were used for the treatment of peptic ulcer disease. Gastric bypass, first described in 1967, has undergone many modifications. It presently exists as a hybrid operation.
M A, Fobi   +3 more
openaire   +2 more sources

Gastric Bypass for Morbid Obesity

Radiology, 1977
Gastric bypass operations have been performed on more than 500 patients at the University of Iowa for the treatment of morbid obesity. With this procedure, almost the entire small intestine remains available for absorption, and the metabolic complications which have been described after jejuno-ileal bypass surgery have not occurred.
W N, Cohen, E E, Mason, T J, Blommers
openaire   +2 more sources

Home - About - Disclaimer - Privacy